From: RNA editing enzymes: structure, biological functions and applications
Methods | Advantages | Disadvantages | References |
---|---|---|---|
A-to-I | Â | Â | |
Exogenous ADAR based | Â | Â | |
λN-BoxB | The small size allows for adeno-associated virus-based delivery. | Low editing efficiency and some bystander editing. | |
SNAP-ADAR | Human origin, small size, chemically stabilized gRNAs are ease to transfect. | It isn’t genetically encodable and unlikely to have therapeutic value. | |
WT ADAR2 | Simultaneous expression of gRNA and ADAR2 in a single plasmid are enough to manipulate disease-related cellular phenotypes. | Can lead to significant transcriptome-wide off-targeting. | [145] |
REPAIR | High editing specificity and easy to viral delivery. | Massive bystander editing. | [146] |
Split-ADAR | High editing precision. Tunable and reversible engineering of cellular RNAs for diverse applications. | Interferon response by the delivery modalities. | |
Bump-Hole | High efficiency and low off-target editing. | With the risk of an antidrug response to the ADAR2 E488Y mutant. | [150] |
CIRTS | It is small in size, suitable for efficient viral packaging and delivery. Low propensity to cause immune reactions. | NA | |
REWIRE | Small size, entirely originated from human, and can be independently applied to achieve simultaneous A-to-I and C-to-U editing in the same transcript. | The editing efficiency RNAs in animals still needs to be optimized. | [153] |
TRIBE | It is beneficial for labelling target RNAs that long-lived interact with RBPs. | The efficiency of single-stranded RNA is reduced, and the substates bias of ADARcd can lead to false negatives. | |
Endogenous ADAR based | Â | Â | |
RESTORE | The editing is achieved only through the administration of the ASOs. | Some degree of off-target. | |
LEAPER | It is safe and the circularization improves the expression level of the gRNA. | A substantial bystander of off-target editing. | |
AIMers | Short, chemically modified oligonucleotides can guide efficient and specific RNA editing. | NA | [159] |
CLUSTER | High precision RNA editing and the editing homeostasis at natural sites was untouched. | Potential immunogenetic or toxic effects of these highly expressed gRNA species. | [160] |
Caged arASO for light triggered RNA editing | Light-triggered RNA point mutation of transcripts in human cells exhibit spatial photoregulation. | Achieving A-to-I editing in CDS of mRNA requires a longer antisense domain. | [161] |
RADARS | Specificity, versatility, simplicity, and generalizable across organ systems and species. | The detection of endogenous transcripts showed variable results. | |
C-to-U editing | Â | Â | |
Exogenous engineered ADAR based | Â | Â | |
RESCUE | Expands the RNA targeting arsenal with C-to-U functionality, and easy for delivery | Accidental transcriptome A-to-I deaminaton limit potential therapeutic uses. | [164] |
RESCUE-S | Minimize the off-target A-to-I conversions. | Reduced on-target C-to-U editing efficiency. | [165] |
SNAP-CDAR-S | Improved the editing of the context of 5’-CCN sequence and improved on-target editing. | There are still notably frequent off-target of A-to-I edits. | |
Endogenous APOBEC based | Â | Â | |
CURE | Both cytoplasmic and nuclear transcripts could be edited. | The strict codon preference and the potential to induce off-target edits in DNA. | [165] |
REWIRE | The editing rate of human cells is high, with a few non-specific editing sites and low levels of off-target globally. | Sequences similar to PUF domain recognition sites may be non-specifically edited. | [153] |